IQCN Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited population of HeLa cells harboring targeted disruption of the IQCN gene. This polyclonal knockout model, generated without single-cell cloning, provides a heterogeneous loss-of-function system suitable for population-level analyses. The CRISPR/Cas9 methodology was employed to introduce gene disruption across the cell pool, effectively abolishing IQCN protein expression and enabling studies of its biological roles in a genetically diverse background.
The parental HeLa cell line is an epithelial model derived from a cervical adenocarcinoma of Henrietta Lacks. These cells are transformed by human papillomavirus type 18 (HPV-18), with viral oncoproteins E6 and E7 inactivating the tumor suppressors p53 and Rb, respectively. This immortalized line exhibits dysregulated cell cycle control and is extensively characterized in cancer research. Its robust proliferative capacity and well-documented molecular landscape make HeLa cells a robust host for gene knockout experiments.
IQCN encodes a protein containing IQ calmodulin-binding motifs, predicted to interact with calmodulin (CALM1/CALM2/CALM3) in a calcium-dependent fashion. Consequently, IQCN likely functions downstream of calcium signals to regulate cytoskeletal organization or ciliogenesis. Key pathway components include calcium ions, calmodulin, myosin, and actin. Through its IQ domains, IQCN may modulate the assembly or dynamics of actin filaments and microtubules, thereby influencing processes such as cell migration, adhesion, and primary cilium formation.
Within the HeLa context, HPV-driven transformation profoundly alters calcium signaling and cytoskeletal architecture. Disruption of IQCN in these cells can uncover its specific contributions to cancer cell motility, invasion, or aberrant ciliogenesis observed in malignant phenotypes. Since calmodulin-mediated pathways are frequently rewired in cancer, this knockout model offers a tractable system to interrogate the role of an IQ domain protein in cytoskeletal regulation under transformed conditions.
Researchers can utilize these polyclonal knockout cells in a variety of assays, including western blotting and RT-qPCR for expression analysis, immunofluorescence and actin staining for cytoskeletal visualization, migration assays for motility assessment, and calcium imaging to monitor signaling dynamics. These applications support functional characterization of IQCN, investigation of calmodulin-mediated cytoskeletal regulation in cancer, and studies of calcium-dependent ciliogenesis. For additional information, please contact Ascent Research.
